Concepts (168)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nicotine | 7 | 2025 | 302 | 1.160 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2023 | 161 | 1.080 |
Why?
|
| RNA-Binding Proteins | 3 | 2023 | 161 | 1.060 |
Why?
|
| Heart | 2 | 2026 | 184 | 0.800 |
Why?
|
| Cotinine | 3 | 2020 | 44 | 0.790 |
Why?
|
| Endoribonucleases | 1 | 2023 | 25 | 0.780 |
Why?
|
| Mice, Obese | 1 | 2020 | 42 | 0.660 |
Why?
|
| Fatty Liver | 2 | 2024 | 77 | 0.610 |
Why?
|
| Myocytes, Cardiac | 2 | 2020 | 183 | 0.600 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2020 | 192 | 0.580 |
Why?
|
| Apoptosis | 3 | 2020 | 1568 | 0.570 |
Why?
|
| Liver Cirrhosis | 1 | 2019 | 67 | 0.570 |
Why?
|
| Myocardium | 1 | 2020 | 263 | 0.560 |
Why?
|
| Iridium | 1 | 2017 | 2 | 0.550 |
Why?
|
| Acenaphthenes | 1 | 2017 | 2 | 0.550 |
Why?
|
| Coordination Complexes | 1 | 2017 | 28 | 0.540 |
Why?
|
| Biomimetic Materials | 1 | 2017 | 24 | 0.540 |
Why?
|
| Mice, Inbred C57BL | 7 | 2025 | 1869 | 0.480 |
Why?
|
| Smoking | 1 | 2020 | 1024 | 0.400 |
Why?
|
| Mice | 8 | 2025 | 6644 | 0.400 |
Why?
|
| Oxidative Stress | 5 | 2024 | 1003 | 0.370 |
Why?
|
| Fibroblasts | 2 | 2014 | 281 | 0.350 |
Why?
|
| Animals | 15 | 2025 | 16992 | 0.310 |
Why?
|
| Tumor Suppressor Protein p53 | 2 | 2008 | 220 | 0.300 |
Why?
|
| Ventricular Dysfunction, Left | 2 | 2020 | 96 | 0.290 |
Why?
|
| Nicotinic Agonists | 2 | 2019 | 88 | 0.280 |
Why?
|
| Ofloxacin | 1 | 2025 | 7 | 0.240 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 2025 | 22 | 0.230 |
Why?
|
| Electrolytes | 1 | 2025 | 30 | 0.230 |
Why?
|
| Maternal Health Services | 1 | 2025 | 23 | 0.230 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2026 | 94 | 0.220 |
Why?
|
| Potassium | 1 | 2025 | 109 | 0.220 |
Why?
|
| AMP-Activated Protein Kinases | 2 | 2025 | 68 | 0.220 |
Why?
|
| Niacinamide | 1 | 2024 | 16 | 0.210 |
Why?
|
| Bangladesh | 7 | 2025 | 29 | 0.210 |
Why?
|
| Pyridinium Compounds | 1 | 2024 | 29 | 0.210 |
Why?
|
| Primate Diseases | 2 | 2013 | 4 | 0.200 |
Why?
|
| Palmitates | 1 | 2023 | 15 | 0.200 |
Why?
|
| Hep G2 Cells | 1 | 2023 | 63 | 0.200 |
Why?
|
| Muscle, Skeletal | 1 | 2025 | 316 | 0.200 |
Why?
|
| Picornaviridae Infections | 2 | 2012 | 2 | 0.190 |
Why?
|
| Picornaviridae | 2 | 2012 | 4 | 0.190 |
Why?
|
| Fatty Acids | 1 | 2023 | 134 | 0.180 |
Why?
|
| Thermodynamics | 2 | 2025 | 229 | 0.180 |
Why?
|
| Pregnancy | 3 | 2025 | 1772 | 0.180 |
Why?
|
| Anti-Bacterial Agents | 1 | 2025 | 432 | 0.180 |
Why?
|
| Male | 8 | 2025 | 23409 | 0.170 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 2020 | 41 | 0.170 |
Why?
|
| Sanitation | 1 | 2020 | 27 | 0.160 |
Why?
|
| Macaca mulatta | 2 | 2013 | 139 | 0.160 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2020 | 160 | 0.160 |
Why?
|
| Echocardiography | 1 | 2020 | 167 | 0.150 |
Why?
|
| Health Services Accessibility | 1 | 2025 | 706 | 0.150 |
Why?
|
| Animals, Newborn | 1 | 2020 | 352 | 0.150 |
Why?
|
| Heart Ventricles | 1 | 2020 | 123 | 0.150 |
Why?
|
| Aerosols | 1 | 2019 | 54 | 0.150 |
Why?
|
| Biopsy, Needle | 1 | 2019 | 59 | 0.150 |
Why?
|
| Disease Models, Animal | 3 | 2019 | 1596 | 0.150 |
Why?
|
| DNA Damage | 2 | 2014 | 356 | 0.150 |
Why?
|
| Blotting, Western | 2 | 2019 | 883 | 0.150 |
Why?
|
| Mice, Knockout | 2 | 2019 | 1035 | 0.150 |
Why?
|
| Random Allocation | 1 | 2019 | 147 | 0.140 |
Why?
|
| Premature Birth | 1 | 2020 | 95 | 0.140 |
Why?
|
| Stroke Volume | 1 | 2019 | 122 | 0.140 |
Why?
|
| Ventricular Function, Left | 1 | 2019 | 114 | 0.140 |
Why?
|
| Solar Energy | 1 | 2017 | 10 | 0.140 |
Why?
|
| Photochemical Processes | 1 | 2017 | 19 | 0.140 |
Why?
|
| Cations | 1 | 2017 | 50 | 0.140 |
Why?
|
| Photosynthesis | 1 | 2017 | 35 | 0.130 |
Why?
|
| Analysis of Variance | 1 | 2019 | 575 | 0.130 |
Why?
|
| Humans | 11 | 2026 | 43102 | 0.130 |
Why?
|
| Quantum Theory | 1 | 2017 | 79 | 0.130 |
Why?
|
| Obesity | 1 | 2025 | 1151 | 0.130 |
Why?
|
| Atherosclerosis | 1 | 2019 | 169 | 0.130 |
Why?
|
| Poverty | 1 | 2020 | 400 | 0.130 |
Why?
|
| RNA, Viral | 3 | 2013 | 321 | 0.130 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 934 | 0.130 |
Why?
|
| Behavior, Animal | 1 | 2019 | 373 | 0.120 |
Why?
|
| Models, Chemical | 1 | 2017 | 204 | 0.120 |
Why?
|
| Telemedicine | 1 | 2020 | 234 | 0.120 |
Why?
|
| Ligands | 1 | 2017 | 388 | 0.120 |
Why?
|
| Feces | 2 | 2012 | 132 | 0.110 |
Why?
|
| Telomeric Repeat Binding Protein 2 | 1 | 2014 | 2 | 0.110 |
Why?
|
| Simian foamy virus | 1 | 2013 | 1 | 0.100 |
Why?
|
| Retroviridae Infections | 1 | 2013 | 4 | 0.100 |
Why?
|
| Stromal Cells | 1 | 2014 | 55 | 0.100 |
Why?
|
| Proviruses | 1 | 2013 | 35 | 0.100 |
Why?
|
| Virus Latency | 1 | 2013 | 49 | 0.100 |
Why?
|
| Skin | 1 | 2014 | 187 | 0.100 |
Why?
|
| Primates | 1 | 2012 | 39 | 0.090 |
Why?
|
| DNA, Mitochondrial | 2 | 2019 | 191 | 0.090 |
Why?
|
| Influenza A Virus, H9N2 Subtype | 1 | 2011 | 1 | 0.090 |
Why?
|
| Influenza A Virus, H5N1 Subtype | 1 | 2011 | 7 | 0.090 |
Why?
|
| Influenza in Birds | 1 | 2011 | 11 | 0.090 |
Why?
|
| Transcription, Genetic | 1 | 2013 | 592 | 0.080 |
Why?
|
| Commerce | 1 | 2011 | 95 | 0.080 |
Why?
|
| Birds | 1 | 2011 | 96 | 0.080 |
Why?
|
| Genetic Variation | 1 | 2012 | 430 | 0.080 |
Why?
|
| Female | 4 | 2025 | 24698 | 0.070 |
Why?
|
| Phylogeny | 2 | 2012 | 769 | 0.070 |
Why?
|
| Hela Cells | 1 | 2008 | 376 | 0.070 |
Why?
|
| Microsatellite Repeats | 1 | 2007 | 61 | 0.070 |
Why?
|
| DNA Repair | 1 | 2008 | 198 | 0.060 |
Why?
|
| Tumor Suppressor Protein p14ARF | 1 | 2006 | 11 | 0.060 |
Why?
|
| Polymorphism, Genetic | 1 | 2007 | 201 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2006 | 56 | 0.060 |
Why?
|
| Micelles | 1 | 2025 | 36 | 0.060 |
Why?
|
| Solutions | 1 | 2025 | 65 | 0.060 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2025 | 104 | 0.060 |
Why?
|
| Health Facilities | 1 | 2025 | 32 | 0.060 |
Why?
|
| Surface-Active Agents | 1 | 2025 | 46 | 0.060 |
Why?
|
| Sequence Analysis, DNA | 3 | 2012 | 515 | 0.060 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 2025 | 388 | 0.050 |
Why?
|
| Temperature | 1 | 2025 | 313 | 0.050 |
Why?
|
| Molecular Sequence Data | 3 | 2012 | 1542 | 0.050 |
Why?
|
| Lipolysis | 1 | 2023 | 20 | 0.050 |
Why?
|
| Pyrazines | 1 | 2023 | 32 | 0.050 |
Why?
|
| Interviews as Topic | 1 | 2025 | 452 | 0.050 |
Why?
|
| Focus Groups | 1 | 2025 | 423 | 0.050 |
Why?
|
| Algorithms | 1 | 2026 | 509 | 0.050 |
Why?
|
| Molecular Epidemiology | 2 | 2012 | 59 | 0.050 |
Why?
|
| Serotyping | 2 | 2012 | 37 | 0.050 |
Why?
|
| Qualitative Research | 1 | 2025 | 574 | 0.050 |
Why?
|
| Liver | 1 | 2024 | 511 | 0.040 |
Why?
|
| Phenotype | 1 | 2023 | 780 | 0.040 |
Why?
|
| Poverty Areas | 1 | 2020 | 47 | 0.040 |
Why?
|
| Family Characteristics | 1 | 2020 | 126 | 0.040 |
Why?
|
| Cluster Analysis | 2 | 2012 | 207 | 0.040 |
Why?
|
| Cytokines | 1 | 2023 | 678 | 0.040 |
Why?
|
| Inhalation Exposure | 1 | 2019 | 44 | 0.040 |
Why?
|
| Apolipoproteins E | 1 | 2019 | 138 | 0.040 |
Why?
|
| Infant, Newborn | 1 | 2020 | 972 | 0.030 |
Why?
|
| Reproducibility of Results | 1 | 2020 | 1081 | 0.030 |
Why?
|
| Parents | 1 | 2020 | 370 | 0.030 |
Why?
|
| Reactive Oxygen Species | 1 | 2019 | 532 | 0.030 |
Why?
|
| Mutation | 1 | 2019 | 1177 | 0.030 |
Why?
|
| Young Adult | 1 | 2025 | 5080 | 0.030 |
Why?
|
| Gene Products, gag | 1 | 2013 | 12 | 0.030 |
Why?
|
| Cheek | 1 | 2013 | 13 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2014 | 196 | 0.030 |
Why?
|
| Haplorhini | 1 | 2012 | 23 | 0.020 |
Why?
|
| Viral Structural Proteins | 1 | 2012 | 17 | 0.020 |
Why?
|
| Sequence Homology | 1 | 2012 | 35 | 0.020 |
Why?
|
| Animals, Zoo | 1 | 2012 | 14 | 0.020 |
Why?
|
| Zoonoses | 1 | 2012 | 21 | 0.020 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 1 | 2014 | 652 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2013 | 247 | 0.020 |
Why?
|
| Cell Cycle Proteins | 1 | 2014 | 241 | 0.020 |
Why?
|
| RNA, Small Interfering | 1 | 2014 | 436 | 0.020 |
Why?
|
| Hemagglutination | 1 | 2011 | 3 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2014 | 526 | 0.020 |
Why?
|
| Polymerase Chain Reaction | 1 | 2012 | 455 | 0.020 |
Why?
|
| Virus Replication | 1 | 2013 | 318 | 0.020 |
Why?
|
| Geography | 1 | 2011 | 110 | 0.020 |
Why?
|
| Cells, Cultured | 1 | 2014 | 1621 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2014 | 1271 | 0.020 |
Why?
|
| Adult | 1 | 2025 | 13872 | 0.020 |
Why?
|
| Cell Proliferation | 1 | 2014 | 1455 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2007 | 62 | 0.020 |
Why?
|
| Models, Genetic | 1 | 2007 | 183 | 0.020 |
Why?
|
| DNA Primers | 1 | 2007 | 294 | 0.020 |
Why?
|
| Demography | 1 | 2007 | 195 | 0.020 |
Why?
|
| Haplotypes | 1 | 2007 | 197 | 0.020 |
Why?
|
| Prevalence | 1 | 2011 | 1612 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2014 | 1019 | 0.010 |
Why?
|
| Base Sequence | 1 | 2007 | 983 | 0.010 |
Why?
|
| Neoplasms | 1 | 2014 | 1377 | 0.010 |
Why?
|
| Models, Biological | 1 | 2006 | 712 | 0.010 |
Why?
|